Kesimpta

ofatumumab · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

48 regulatory and trial events tracked for Kesimpta, covering 2009-10-26 to 2026-08-20. Get the full timeline:

Most recent: EMA Authorised: Kesimpta (ofatumumab) — Novartis Europharm Limited